Rob Draper for Precision IO
01

The first company to pair its own ablation energy with a cleared placement robot.

Quantum Surgical acquired NeuWave from J&J in February 2026, and both now sit under Precision IO. The two businesses still sell separately. The revenue is in selling them as one.

Three numbers that frame the opportunity.

70%+Sourceof the top US cancer centers already use NeuWave. These interventional radiology teams are the warmest robot prospects in the country.
1,400+Sourcepatients treated with Epione in Europe and the US. FDA cleared for abdominal ablation with CT. CE marked for abdomen, chest and musculoskeletal.
~$1.8BSourceglobal tumor ablation market in 2025, growing about 10% a year. Percutaneous procedures are two thirds of it, and microwave is the largest technology.

Eight months that changed the company.

Sep 2025SourceJ&J finds a buyer. J&J MedTech names a buyer for NeuWave after signaling an exit.
Feb 2026SourcePrecision IO is formed. Quantum Surgical acquires NeuWave. Kurt Azarbarzin, formerly of Verb Surgical, becomes CEO, backed by Ally Bridge Group.
Apr 2026SourceEPIOS opens. The first US patient is treated in the Epione bone lesion study.
Jul 2026SourceRemote program. Epione and remote intervention are presented at the Society of Robotic Surgery.
Sep 2026SourceAI and imaging. AI segmentation and GE HealthCare angiography integration are unveiled at CIRSE.

Five ways in. Two pay now. Three open new markets.

The robot is more than a NeuWave add on. It gets Precision IO into rooms, organs and departments it does not reach today. The rings show how soon each one pays.

Now Next Later Epione robot 01NeuWave base 02Competitor sites 03New organs 04Community hospitals 05Radiation oncology

  1. NeuWave accounts: add the robot.

    Interventional radiology teams already running NeuWave cases. No cold introduction, and a disposables relationship to build on.

    Now · 70%+ of top US cancer centers

  2. Competitor accounts: get in with the robot.

    Sites on Medtronic, AngioDynamics or Boston Scientific energy have no placement robot. Epione works with the energy they own today, and NeuWave can follow.

    Now · Open architecture: any energy

  3. New organs bring new physicians.

    Kidney brings urology, bone brings orthopedic oncology, and lung brings thoracic teams as clearances arrive. Each is a new buyer inside an account we already serve.

    Next · EPIOS US bone study since Apr 2026

  4. Community hospitals.

    Programs without a deep interventional radiology bench. Robotic planning helps newer physicians take on complex cases, so patients stay close to home.

    Next · Remote intervention program

  5. Radiation oncology and brachytherapy.

    My home market. Teams that already place needles by template understand precise placement. Prostate needs new imaging, clearance and data first.

    Later · The longer bet

Analysts disagree on the size, not the direction.

AnalystBaseForecastGrowth a year
Mordor Intelligence$1.76B in 2025$3.14B in 203110.2%
IMARC Group$1.31B in 2024$3.20B in 203310.4%
MarketsandMarkets$0.8B in 2024$1.4B in 202910.0%
Fortune Business Insights$0.85B in 2025$1.58B in 20347.2%